# PRACTECAL-PKPD Sub Study

> **NCT04081077** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Medecins Sans Frontieres, Netherlands** · enrollment: 240 (estimated)

## Conditions studied

- Multi-drug Resistant Tuberculosis
- Extensively Drug-Resistant Tuberculosis
- Pulmonary Tuberculosis

## Interventions

- **DRUG:** Bedaquiline
- **DRUG:** Pretomanid
- **DRUG:** Moxifloxacin
- **DRUG:** Linezolid
- **DRUG:** Clofazimine

## Key facts

- **NCT ID:** NCT04081077
- **Lead sponsor:** Medecins Sans Frontieres, Netherlands
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-06
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2021-05-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04081077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04081077, "PRACTECAL-PKPD Sub Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04081077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*